Centerpoint Advisors, LLC Vaxart, Inc. Transaction History

Centerpoint Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$5.77 - $7.96 $288 - $398	-50 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$5.06 - $10.78 $505 - $1,078	-100 Reduced 66.67%	50 $0
Q1 2021 Apr 23, 2021	BUY	$5.64 - $23.33 $282 - $1,166	50 Added 50.0%	150 $1,000
Q4 2020 Jan 22, 2021	BUY	$3.5 - $7.98 $350 - $798	100 New	100 $1,000
Q3 2020 Oct 13, 2020	SELL	$4.78 - $16.97 $956 - $3,394	-200 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$1.68 - $8.85 $336 - $1,770	200 New	200 $2,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Centerpoint Advisors, LLC with notifications on news.